English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Daniel Daw
| Mar 6, 2016
Study details IPF patient experiences
Daniel Daw
| Jan 24, 2016
Leukemia treatment candidate receives FDA breakthrough designation
Daniel Daw
| Jan 23, 2016
Medical groups call for smoking ban in public housing facilities
Daniel Daw
| Jan 23, 2016
FDA issues women's health roadmap
Daniel Daw
| Jan 23, 2016
AAFP issues commentary on proposed opioid prescription guidelines
Daniel Daw
| Jan 6, 2016
Proteasomes may open doors to neurodegenerative treatment potential
Daniel Daw
| Jan 6, 2016
FDA welcomes participation at drug development meetings
Daniel Daw
| Jan 1, 2016
AHA issues statement in response to spending bill
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
Coalition warns against potential impact of H.R. 1 on patient healthcare access
